Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 11.50p 11.00p 12.00p 11.50p 11.50p 11.50p 68,721 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 13.6 -6.9 -0.4 - 15

Omega Diagnostics Share Discussion Threads

Showing 3701 to 3725 of 3725 messages
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
DateSubjectAuthorDiscuss
18/10/2019
16:47
I see the IDS share price has been on the rise over the last few months, a reasonable Trading update today...
barrywhit
18/10/2019
11:54
As with all contracts they take months even years to sign if they are for multi million pound orders :-)
leedslad001
18/10/2019
08:38
Dear upomega, they shook the crumbs out of the bread basket before the fund raise, yet you demand more? Best of British. Yours etc. O. Twist
gwr7
16/10/2019
09:11
Upomega, we all know as much as you, but I’m sure ODX will let us know when they receive orders. They need the share price higher as we do to appease the major holders..
barrywhit
16/10/2019
08:59
Does anyone know if we have received any orders on the back of eprd approval
upomega
14/10/2019
09:50
If sales do not materialize soon. I would hope they cut expenditure on cd4 and concentrate on food intolerance. After all this should be highly profitable in the short term
upomega
14/10/2019
09:20
Very true bomber, but they need to start attracting new investors, they cannot keep relying on Richard Sneller to pick up placing shares. We need to see they can sell both types of CD4 in volume...
barrywhit
14/10/2019
09:04
It looks like Richard Sneller has already added to his new shareholding . His holding has risen 601/- shares since Friday's website update to 24.98% . One suspects this may have something to do with the delayed trade of 1.37m at 10p from Friday . Given that was the placing price , does this mean one of the placees couldn't take up their allotment , and Sneller has stepped in ? Given that Sneller was less than half this trade , does this also mean AN Other has stepped in to help ?
bomber13
13/10/2019
19:22
Yup , agreed barrywhit , who took them ? Even though Harwood took some new shares , none of the other 8 of the 10 top shareholders took any new shares at all , thereby suffering maximum dilution . I cannot believe they were not offered the stock ? Which leads me to think maybe one or two new institutions have come in , and yet have stayed under the radar .
bomber13
13/10/2019
15:17
bomber, so where did Finncap place the other 7.059.642...........
barrywhit
13/10/2019
15:15
I hope your right bomber about the next few weeks. It would be good to see a large cd4 sale materialising.
upomega
13/10/2019
11:14
Thanks barrywhit . Interesting to note that of the top ten shareholders , only one , the largest , Richard Sneller , increased his percentage holding post the £1.7m fundraising . His holding went from 22.1% to 24.58% , all the other nine were diluted in a small way . We also know that Harwood Capital took 930/- new shares , 5.4% of the issue , but below its 12% prior stake in Omega . Moreover , we know that the directors took 935/- new shares , and that the largest allotment , 500/- shares or 3% of the issue , was to the new NED , Jeremy Millard , Sneller's brother-in-law . It promises to be an exciting few weeks ahead with the focal point being the AGM on Tuesday week .
bomber13
12/10/2019
17:36
Updated Share Register on the website...
barrywhit
11/10/2019
15:15
My understanding was that once cd4200 was eprd approved it would be rolled out in several countries by an aid agency. So something has gone wrong somewhere
upomega
11/10/2019
15:15
My understanding was that once cd4200 was eprd approved it would be rolled out in several countries by an aid agency. So something has gone wrong somewhere
upomega
11/10/2019
10:31
At least we do not have to worry about funding for at least the next 12 months now the shares have been admitted to AIM...all we need now are some orders...
barrywhit
08/10/2019
23:01
The General Meeting to approve the £1.7m fund-raising is on Thursday this week , so my guess would be that we get the interim trading update with the AGM statement on 22nd October .Omega has already confirmed that current trading is in line with management expectations just over 2 weeks ago , so it seems unlikely that we will get any other message .Very hopefully , we may also get CFDA approval of Food Detective in Chinese laboratories , and Nigerian MOH approval of Visitect 350 any day now .The fund-raising has already helped confidence enormously given it will wipe out the overdraft , and soon after the general meeting we will have RNS's confirming increased stakes by Richard Sneller and Harwood Capital . Perhaps of more interest will be to see if any new investor(s) has subscribed for shares ?
bomber13
08/10/2019
17:29
Does anyone have any views as to what we can expect from the trading update
upomega
03/10/2019
18:35
we should get a trading update soon. It would be nice if we are ahead of management expectations.I am wondering if the Chinese orders came in ahead of when they were expecting them.
upomega
01/10/2019
21:31
This is the bit where I say ‘There must be a large buy order in the background getting filled’ and then the share price duly drops!
dibs61
01/10/2019
13:33
There seems to be a number of large sales going through. Hopefully this is a final clear out.At least the price is holding up though.
upomega
30/9/2019
13:24
up - yes I’m aware of that however the WHO status for the application was stuck on information requested from manufacturer for some time after the point at which we thought they had submitted. So I’m being somewhat cautious with my forecast because there may have been a hold up which has now resolved. They did say FY21.
dibs61
30/9/2019
12:24
Dibs. My understanding was that cd4 was logged with who at the same time as eprd. So if that is the case we are already 90 days into this process.
upomega
30/9/2019
10:00
We are at the ‘dossier review’ stage in the WHO prequalification process. This is progress because the last time I looked the status was ‘information requested from manufacturer’ hxxps://www.who.int/diagnostics_laboratory/cd4.pdf?ua=1 According to my research on the WHO website the average time it takes for the WHO prequalifcation process to complete is 270 days. So, on that basis we should, all being well, receive approval in June or July next year. hxxps://www.who.int/diagnostics_laboratory/streamlining/en/index6.html
dibs61
29/9/2019
18:53
Something which hopefully should occur shortly. Is an an order for cd4 on the back of erpd approval. If that occurs then that will bridge a gap until who approval.inmo
upomega
Chat Pages: 149  148  147  146  145  144  143  142  141  140  139  138  Older
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 11:57:27